Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20024594HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20016183HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20016155HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20016116HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20015095HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20015096HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20016170HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20048008HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20067422HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TVIS20064894HPVENSG00000196482.18protein_codingESRRGNoNo2104P62508
TCGA Plot Options
Drug Information
GeneESRRG
DrugBank IDDB00197
Drug NameTroglitazone
Target IDBE0002088
UniProt IDP62508
Regulation Typeinverse agonist
PubMed IDs20298676
CitationsWang Y, Fang F, Wong CW: Troglitazone is an estrogen-related receptor alpha and gamma inverse agonist. Biochem Pharmacol. 2010 Jul 1;80(1):80-5. doi: 10.1016/j.bcp.2010.03.013. Epub 2010 Mar 16.
GroupsApproved; Investigational; Withdrawn
Direct Classification1-benzopyrans
SMILESCC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Pathways
PharmGKBPA451799
ChEMBLCHEMBL408